Company / Working Capital
SOLENO THERAPEUTICS INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$294.5M
FY2025
5-year range
$8.3M / $294.5M
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#145 of 215
Health Care
What the data says
At $294M, SOLENO THERAPEUTICS INC's working capital ranks #145 of 215 in the Health Care sector. Working Capital has increased for 3 consecutive years, from $8M in FY2022 to $294M in FY2025.
Based on SEC 10-K filings.
$294M in FY2025 with a 5-year CAGR of +47.9%.
Improved from $160M to $294M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +228.1%
- 5-Year CAGR
- +47.9%
- 10-Year CAGR
- -
Sector benchmark
#145 of 215 in Health CareTop 67% of 215This company $294.5M Sector average $957.8M
▼
-69.3% below sector average
Key checks
Key Insights
- SOLENO THERAPEUTICS INC's working capital has grown for 3 consecutive years.
- 5-year CAGR of +47.9%, indicating consistent growth.
- In FY2025, working capital increased 7.0% year-over-year.
- Ranks #145 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $294.5M | +7.0% |
| FY2024 | $275.1M | +72.1% |
| FY2023 | $159.9M | +1818.1% |
| FY2022 | $8.3M | -42.2% |
| FY2021 | $14.4M | -65.4% |
| FY2020 | $41.6M | +157.3% |
| FY2019 | $16.2M | -29.0% |
| FY2018 | $22.8M | +40.2% |
| FY2017 | $16.3M | +676.6% |
| FY2016 | $2.1M | -34.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026